Alden Kandic

Alden Kandic has a comprehensive work experience in the pharmaceutical and healthcare industry. Alden is currently serving as the Head of Quality, VP at Procella Therapeutics AB since May 2022. Prior to this, they worked at Sobi - Swedish Orphan Biovitrum AB (publ) from 2013 to 2022, where they held various roles including Head of QA Haematology & Qualified Person, Head of QA/QC IM, Qualified Person, Director & Qualified Person, QA IM, Director QA Haemophilia, and Delegated Qualified Person. Alden also worked at Crucell Sweden AB as a Quality Assurance professional in 2013 and at Apoteket Produktion & Laboratorier as a QA/QC specialist from 2010 to 2013. Alden started their career at Diamyd Medical as a Quality Manager from 2009 to 2010.

From 2004 to 2009, Alden Kandic attended Mälardalen University, where they pursued a Master of Science (MSc) degree. The field of study associated with this degree is not specified.